Congress quietly doubles funding for sickle cell research
S. 735 — Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 · Filed by Tim Scott (R-SC) · 3 cosponsors · Introduced Feb 26, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill reauthorizes and expands a federal program that funds research, treatment, and prevention of sickle cell disease and related blood disorders. It increases annual funding from $4.5 million to $8.2 million for fiscal years 2025–2029, broadens the program to include prevention of complications (not just the disease itself), and allows grants in addition to contracts. The bill benefits patients with sickle cell disease, researchers, and treatment providers by increasing resources for a disease that disproportionately affects Black Americans.
Why we flagged it
The bill's sole operative mechanism is reauthorization and expansion of a federal research and treatment program for a specific disease. It is straightforward public health legislation with no hidden provisions or private carve-outs.
What the text implies
- Shift from 'prevention and treatment' to 'treatment and prevention of complications' may subtly narrow focus from primary prevention (e.g., genetic counseling, carrier screening) to clinical management of existing disease, though the practical impact depends on implementation.
- Expansion to 'heritable blood disorders' beyond sickle cell (e.g., thalassemia, hemophilia) is stated in the sense-of-Congress clause but not explicitly funded in the reauthorization amount, creating potential ambiguity about whether the $8.2M covers both or primarily sickle cell.
The full analysis lists 3 implications of this text.
Who stands to gain
academic medical centers and research institutions; sickle cell disease treatment and research organizations; public health agencies and state health departments